Showing 1 - 20 results of 34 for search 'Sinda Zarrouk-Mahjoub', query time: 0.06s Refine Results
  1. 1
    Mitochondrial myopathy, dysmorphism, exercise-induced vomiting and tachycardia the mutation m.4831G > A

    Mitochondrial myopathy, dysmorphism, exercise-induced vomiting and tachycardia the mutation m.4831G > A by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2017-06-01
    Get full text
    Article
  2. 2
    MELAS syndrome due to the m.3291T>C mutation

    MELAS syndrome due to the m.3291T>C mutation by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2016-06-01
    Get full text
    Article
  3. 3
    Onset of MELAS due to the m.3243A>G mutation is early if the large phenotypic variability is considered

    Onset of MELAS due to the m.3243A>G mutation is early if the large phenotypic variability is considered by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2017-03-01
    Get full text
    Article
  4. 4
    Pancreatitis in mitochondrial disorders

    Pancreatitis in mitochondrial disorders by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2017-03-01
    Get full text
    Article
  5. 5
    Stroke in MELAS is a Vasogenic Edema and not Ischemic

    Stroke in MELAS is a Vasogenic Edema and not Ischemic by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2020-05-01
    Get full text
    Article
  6. 6
    Phenotypic heterogeneity of a compound heterozygous SUCLA2 mutation

    Phenotypic heterogeneity of a compound heterozygous SUCLA2 mutation by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2017-03-01
    Get full text
    Article
  7. 7
    Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism

    Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2018-03-01
    Get full text
    Article
  8. 8
    Pathogenicity of the Homoplasmic m.8701A>G Variant Requires Confirmation

    Pathogenicity of the Homoplasmic m.8701A>G Variant Requires Confirmation by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2016-01-01
    Get full text
    Article
  9. 9
    Posterior Spinal Instrumented Fusion for Idiopathic Scoliosis in Patients with Multisystemic Neurodegenerative Disorder: A Report of Two Cases

    Posterior Spinal Instrumented Fusion for Idiopathic Scoliosis in Patients with Multisystemic Neurodegenerative Disorder: A Report of Two Cases by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2016-12-01
    Get full text
    Article
  10. 10
    Mitochondrial Disorders May Mimic Amyotrophic Lateral Sclerosis at Onset

    Mitochondrial Disorders May Mimic Amyotrophic Lateral Sclerosis at Onset by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2016-02-01
    Get full text
    Article
  11. 11
    Diagnosing Kearns-Sayre Syndrome Requires Genetic Confirmation

    Diagnosing Kearns-Sayre Syndrome Requires Genetic Confirmation by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2016-01-01
    Get full text
    Article
  12. 12
    Traumatic brain injury is unlikely precipitating Leigh syndrome due to the GJB2 mutation c.35delG

    Traumatic brain injury is unlikely precipitating Leigh syndrome due to the GJB2 mutation c.35delG by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2017-06-01
    Get full text
    Article
  13. 13
    ND2 mutation with minimal coenzyme-Q responsive manifestations

    ND2 mutation with minimal coenzyme-Q responsive manifestations by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2017-03-01
    Get full text
    Article
  14. 14
    Traumatic brain injury is unlikely precipitating Leigh syndrome due to the GJB2 mutation c.35delG

    Traumatic brain injury is unlikely precipitating Leigh syndrome due to the GJB2 mutation c.35delG by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2017-03-01
    Get full text
    Article
  15. 15
    Costs for mitochondrial medicine will remain high as long as mitochondrial disorders are misdiagnosed

    Costs for mitochondrial medicine will remain high as long as mitochondrial disorders are misdiagnosed by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2017-12-01
    Get full text
    Article
  16. 16
    KEARNS-SAYRE SYNDROME MIGHT BE MIXED UP WITH CPEO PLUS

    KEARNS-SAYRE SYNDROME MIGHT BE MIXED UP WITH CPEO PLUS by Josef Finsterer, Sinda Zarrouk- Mahjoub

    Published 2019-01-01
    Get full text
    Article
  17. 17
    Left ventricular hypertrabeculation/noncompaction in hyperoxaluria

    Left ventricular hypertrabeculation/noncompaction in hyperoxaluria by Josef Finsterer, Sinda Zarrouk-mahjoub

    Published 2015-09-01
    Get full text
    Article
  18. 18
    MELAS reflects a clinical concept with heterogeneous genetic background

    MELAS reflects a clinical concept with heterogeneous genetic background by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Get full text
    Article
  19. 19
    Treating mitochondrial disorders requires full exploitation of available therapeutic options

    Treating mitochondrial disorders requires full exploitation of available therapeutic options by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2017-12-01
    Get full text
    Article
  20. 20
    Letter to the Editor: Maternally Inherited Diabetes and Deafness is Not Only Biorgan but Multiorgan

    Letter to the Editor: Maternally Inherited Diabetes and Deafness is Not Only Biorgan but Multiorgan by Josef Finsterer, Sinda Zarrouk-Mahjoub

    Published 2017-09-01
    Get full text
    Article

Search Tools: